Mail Smith writes on the Americans United for Life Blog:
Today the biotech company Geron will make an unprecedented announcement: the U.S. Food and Drug Administration (FDA) has agreed to allow the company to conduct human trials utilizing human embryonic stem cells.
Ironically (or perhaps not), the FDA’s decision came right after President Obama’s inauguration. It is just one of the many steps planned by the new administration to tear down the walls protecting human life . . .
